The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 337:1914-1915 December 25, 1997 Number 26
NextNext

The Perils of Platelet Transfusions

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
The value of platelet transfusions for thrombocytopenia was first reported in 1910, when Duke described three patients with bleeding due to thrombocytopenia, each of whom showed improvement with transfusions of platelet-containing fresh, whole blood.1 This discovery was followed by the development of techniques to prepare platelet components, and platelet transfusions were shown to reduce the risk of death from hemorrhage substantially during chemotherapy for leukemia. The current reliance on platelet transfusions is reflected by the fact that in the United States there has been an increase in such transfusions of 5 to 7 percent annually since 1987, even as red-cell . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.